Zapatka M - Search Results

1

Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma.

Becker JC, Andersen MH, Hofmeister-Müller V, Wobser M, Frey L, Sandig C, Walter S, Singh-Jasuja H, Kämpgen E, Opitz A, Zapatka M, Bröcker EB, Thor Straten P, Schrama D, Ugurel S. Becker JC, et al. Among authors: zapatka m. Cancer Immunol Immunother. 2012 Nov;61(11):2091-103. doi: 10.1007/s00262-012-1266-9. Epub 2012 May 8. Cancer Immunol Immunother. 2012. PMID: 22565484 Free PMC article. Clinical Trial.

2

Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy.

Ugurel S, Schrama D, Keller G, Schadendorf D, Bröcker EB, Houben R, Zapatka M, Fink W, Kaufman HL, Becker JC. Ugurel S, et al. Among authors: zapatka m. Cancer Immunol Immunother. 2008 May;57(5):685-91. doi: 10.1007/s00262-007-0407-z. Epub 2007 Oct 2. Cancer Immunol Immunother. 2008. PMID: 17909797 Free PMC article.

3

ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln polymorphisms are independent prognostic factors for the clinical course of melanoma.

Schrama D, Scherer D, Schneider M, Zapatka M, Bröcker EB, Schadendorf D, Ugurel S, Kumar R, Becker JC. Schrama D, et al. Among authors: zapatka m. J Invest Dermatol. 2011 Jun;131(6):1280-90. doi: 10.1038/jid.2011.35. Epub 2011 Mar 10. J Invest Dermatol. 2011. PMID: 21390047 Free article.

4

STAT3 Single Nucleotide Polymorphism rs4796793 SNP Does Not Correlate with Response to Adjuvant IFNα Therapy in Stage III Melanoma Patients.

Schrama D, Ugurel S, Sucker A, Ritter C, Zapatka M, Schadendorf D, Becker JC. Schrama D, et al. Among authors: zapatka m. Front Med (Lausanne). 2014 Nov 28;1:47. doi: 10.3389/fmed.2014.00047. eCollection 2014. Front Med (Lausanne). 2014. PMID: 25593920 Free PMC article.

5

Microphthalmia-associated transcription factor gene amplification in metastatic melanoma is a prognostic marker for patient survival, but not a predictive marker for chemosensitivity and chemotherapy response.

Ugurel S, Houben R, Schrama D, Voigt H, Zapatka M, Schadendorf D, Bröcker EB, Becker JC. Ugurel S, et al. Among authors: zapatka m. Clin Cancer Res. 2007 Nov 1;13(21):6344-50. doi: 10.1158/1078-0432.CCR-06-2682. Clin Cancer Res. 2007. PMID: 17975146

6

Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma.

Schrama D, Peitsch WK, Zapatka M, Kneitz H, Houben R, Eib S, Haferkamp S, Moore PS, Shuda M, Thompson JF, Trefzer U, Pföhler C, Scolyer RA, Becker JC. Schrama D, et al. Among authors: zapatka m. J Invest Dermatol. 2011 Aug;131(8):1631-8. doi: 10.1038/jid.2011.115. Epub 2011 May 12. J Invest Dermatol. 2011. PMID: 21562568 Free article.

7

Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.

Paschen A, Sucker A, Hill B, Moll I, Zapatka M, Nguyen XD, Sim GC, Gutmann I, Hassel J, Becker JC, Steinle A, Schadendorf D, Ugurel S. Paschen A, et al. Among authors: zapatka m. Clin Cancer Res. 2009 Aug 15;15(16):5208-15. doi: 10.1158/1078-0432.CCR-09-0886. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671853

8

Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling.

Findeisen P, Zapatka M, Peccerella T, Matzk H, Neumaier M, Schadendorf D, Ugurel S. Findeisen P, et al. Among authors: zapatka m. J Clin Oncol. 2009 May 1;27(13):2199-208. doi: 10.1200/JCO.2008.18.0554. Epub 2009 Mar 23. J Clin Oncol. 2009. PMID: 19307507

9

Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.

Helgason HH, Engwegen JY, Zapatka M, Vincent A, Cats A, Boot H, Beijnen JH, Schellens JH. Helgason HH, et al. Among authors: zapatka m. Oncol Rep. 2010 Jul;24(1):57-64. doi: 10.3892/or_00000828. Oncol Rep. 2010. PMID: 20514444

10

Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer.

Gast MC, Zapatka M, van Tinteren H, Bontenbal M, Span PN, Tjan-Heijnen VC, Knol JC, Jimenez CR, Schellens JH, Beijnen JH. Gast MC, et al. Among authors: zapatka m. J Cancer Res Clin Oncol. 2011 Dec;137(12):1773-83. doi: 10.1007/s00432-011-1055-4. Epub 2011 Sep 13. J Cancer Res Clin Oncol. 2011. PMID: 21913038 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page